(S (S (VP (VBG Determining) (NP (NP (DT the) (JJ primary) (NN site)) (PP (IN of) (NP (NN origin))) (PP (IN for) (NP (JJ metastatic) (NNS tumors)))))) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (JJ open) (NNS problems)) (PP (IN in) (NP (NN cancer) (NN care)))))) (SBAR (IN because) (S (NP (NP (DT the) (NN efficacy)) (PP (IN of) (NP (NN treatment)))) (ADVP (RB often)) (VP (VBZ depends) (PP (IN on) (NP (NP (DT the) (NN cancer) (NN tissue)) (PP (IN of) (NP (NN origin))))))))) (. .))
(S (NP (NP (NNP Classification) (NNS methods)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VP (VB leverage) (NP (JJ tumor) (JJ genomic) (NNS data))) (CC and) (VP (VBP predict) (NP (NP (DT the) (NN site)) (PP (IN of) (NP (NN origin)))))))))) (VP (VBP are) (ADVP (RB therefore)) (PP (IN of) (NP (JJ great) (NN value)))) (. .))
(S (SBAR (IN Because) (S (NP (NN tumor) (NNP DNA) (NN point) (NN mutation) (NNS data)) (VP (VBZ is) (ADJP (RB very) (JJ sparse))))) (, ,) (NP (NP (RB only) (JJ limited) (NN accuracy)) (PRN (-LRB- -LRB-) (NP (NP (CD 64.5) (NN %)) (PP (IN for) (NP (CD 12) (NN tumor) (NNS classes)))) (-RRB- -RRB-))) (VP (VBD was) (ADVP (RB previously)) (VP (VP (VBN demonstrated) (PP (IN by) (NP (NP (NNS methods)) (SBAR (WHNP (WDT that)) (S (VP (VBP rely) (PP (IN on) (NP (NN point) (NNS mutations))) (PP (IN as) (NP (NNS features))))))))) (PRN (-LRB- -LRB-) (INTJ (CD 1)) (-RRB- -RRB-)))) (. .))
(S (NP (NNP Tumor) (NN classification) (NN accuracy)) (VP (MD can) (VP (VB be) (VP (ADVP (RB greatly)) (VBN improved) (PRN (-LRB- -LRB-) (PP (TO to) (NP (NP (QP (VB over) (CD 90)) (NN %)) (PP (IN for) (NP (CD 33) (NNS classes))))) (-RRB- -RRB-)) (PP (IN by) (S (VP (VBG relying) (PP (IN on) (NP (NP (NN gene) (NN expression) (NNS data)) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-)))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (DT this) (JJ additional) (NN data)) (VP (VBZ is) (ADVP (RB often)) (ADJP (RB not) (ADJP (RB readily) (JJ available))) (PP (IN in) (NP (JJ clinical) (NN setting))) (, ,) (SBAR (IN because) (S (NP (NN point) (NNS mutations)) (VP (VBP are) (VP (ADVP (RB better)) (VBN profiled) (CC and) (VBN targeted) (PP (IN by) (NP (JJ clinical) (JJ mutational) (NN profiling)))))))) (. .))
(S (ADVP (RB Here)) (NP (PRP we)) (VP (VBD sought) (S (VP (TO to) (VP (VB develop) (NP (NP (DT an) (JJ accurate) (NN deep) (NN transfer) (NN learning) (CC and) (JJ fine-tuning) (NN method)) (PP (IN for) (NP (NP (NN tumor) (JJ sub-type) (NN classification)) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (VBN predicted) (NN class)) (VP (VBZ is) (ADJP (JJ indicative) (PP (IN of) (NP (NP (DT the) (JJ primary) (NN site)) (PP (IN of) (NP (NN origin)))))))))))))))) (. .))
(S (NP (PRP$ Our) (NN method)) (VP (ADVP (RB significantly)) (VBZ outperforms) (NP (NP (DT the) (NN state-of-the-art)) (PP (IN for) (NP (NN tumor) (NN classification))) (VP (VBG using) (NP (NNP DNA) (NN point) (NNS mutations)))) (, ,) (S (VP (VBG reducing) (NP (DT the) (NN error)) (PP (IN by) (NP (QP (JJR more) (IN than) (CD 30)) (NN %))) (PP (IN at) (NP (DT the) (JJ same) (NN time))) (VP (VBG discriminating) (PP (IN over) (NP (JJ many) (JJR more) (NNS classes))) (PP (IN on) (NP (DT The) (NNP Cancer) (NNP Genome) (NNP Atlas) (PRN (-LRB- -LRB-) (NP (NNP TCGA)) (-RRB- -RRB-)) (NN dataset))))))) (. .))
(S (S (VP (VBG Using) (NP (PRP$ our) (NN method)))) (, ,) (NP (PRP we)) (VP (VBP achieve) (NP (NP (JJ state-of-the-art) (NN tumor) (NN type) (NN classification) (NN accuracy)) (PP (IN of) (NP (CD 78.3) (NN %)))) (PP (IN for) (NP (CD 29) (NN tumor) (NNS classes))) (S (VP (VBG relying) (PP (IN on) (NP (NP (NP (NNP DNA) (NN point) (NNS mutations)) (PP (IN in) (NP (DT the) (NN tumor)))) (ADVP (RB only))))))) (. .))
